Harris S

ORCID: 0000-0003-2306-7921 · 4 papers in corpus
other 2021
Canadian Society of Thoracic Radiology/Canadian Association of Radiologists Clinical Practice Guidance for Non-Vascular Thoracic MRI
Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes ·doi:10.1177/0846537121998961

Historically thoracic MRI has been limited by the lower proton density of lung parenchyma, cardiac and respiratory motion artifacts and long acquisition times. Recent technological advancements in MR hardware systems and improvement in MR p…

2018
Assessment of demographic and perinatal predictors of non-response and impact of non-response on measures of association in a population-based case control study: findings from the Georgia Study to Explore Early Development.
Emerging themes in epidemiology ·doi:10.1186/s12982-018-0081-y

BackgroundParticipation in epidemiologic studies has declined, raising concerns about selection bias. While estimates derived from epidemiologic studies have been shown to be robust under a wide range of scenarios, additional empiric study …

article 2017
Maternal and Paternal Infertility Disorders and Treatments and Autism Spectrum Disorder: Findings from the Study to Explore Early Development
Journal of autism and developmental disorders ·doi:10.1007/s10803-017-3283-1

Previous studies of associations between ASD and conception using assisted reproductive technology (ART) are inconsistent and few studies have examined associations with other infertility treatments or infertility disorders. We examined ass…

article 1997
A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.3109/09513599709152533

The objective of this study was to compare the efficacy of nafarelin 200 micrograms (Group A), nafarelin 400 micrograms (Group B) and the combination of nafarelin 200 micrograms and norethisterone 1.2 mg (Group C) daily, in treating symptom…